Category: Diagnostic Technologies

Diagnostic Technologies

Building a Better Picture of Cancer

Clinical labs are adopting broader cancer diagnostics—including whole-genome sequencing and multi-omic testing—to deliver more comprehensive molecular insights and improve disease monitoring.

Diagnostic Technologies

OnsiteGene Introduces Handheld 10-Minute Real-Time PCR Instrument

OnsiteGene has unveiled myNAT, a handheld, battery-powered real-time PCR instrument capable of 40-cycle runs in under 10 minutes, with a target cost of under $5 per test, according to the company.

Diagnostic Technologies

The Cyclospora Outbreak Is Putting Laboratory Testing to the Test

As Cyclospora infections surge in the US, laboratories face increased pressure to quickly differentiate cases, with the CDC reporting 1,947 confirmed infections and 98 hospitalizations across nine states as of July 24.

Anatomic Pathology

RDi USA Launches at ADLM 2026 with Automated Diagnostic Kitting Platform

The company says its US business combines automated kit manufacturing, fulfillment, sample logistics, and digital workflow technology into a single diagnostic testing platform.

Digital Pathology

Pictor Unveils High-Resolution Protein Analysis Platform at ADLM 2026

The research-use-only platform combines imaging, software, and multiplex protein analysis into a standard 96-well workflow designed to simplify biomarker research.

Clinical Chemistry

Immunoassays May Underestimate HbA1c in Patients with Sickle Cell Trait

Research presented at ADLM 2026 indicates immunoassays may significantly underestimate HbA1c in patients with sickle cell trait, suggesting HPLC offers more reliable diabetes screening for populations with hemoglobin variants.

Flow Cytometry

ARUP Laboratories Launches Spectral Flow Cytometry Test for Multiple Myeloma Monitoring

The assay is designed to detect minimal residual disease with greater sensitivity than conventional flow cytometry.

Hematology & Serology

Sysmex America to Feature New Hematology and Hemostasis Solutions at ADLM 2026

Sysmex America will showcase the XR-Series hematology platform and CentralOps informatics solution at ADLM 2026, highlighting advancements for high-volume clinical labs in hematology, hemostasis, and data integration.

Immunoassay

Alamar Gains Rights to Develop Clinical Alzheimer’s Blood Tests Using ALZpath Antibody

ALZpath and Alamar Biosciences have expanded their partnership, granting Alamar commercial rights to use ALZpath’s pTau217 antibody in clinical blood tests for Alzheimer’s disease.

Mass Spectrometry

Thermo Fisher Highlights New FDA-Cleared Diagnostics at ADLM 2026

The company is showcasing newly cleared tests and platforms for multiple myeloma, lung cancer, connective tissue disease, and other laboratory applications.

Microbiology

Study to Evaluate One-Hour Testing for Drug-Resistant Infections

The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.

Molecular Diagnostics

Labcorp Launches Consumer Genetic Health Panel for Hereditary Risk Assessment

Labcorp has announced the upcoming launch of the Marker by Labcorp Genetic Health Panel, which will analyze 163 genes linked to over 100 medically actionable conditions, with results supported by licensed genetic counselors.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Beckman Coulter Launches DxU 1800 Automated Urinalysis System to Streamline Lab Workflows

The automated urinalysis system integrates chemistry and microscopy to help labs manage higher testing volumes and reduce manual reviews to under 3%, according to the company.